Testosterone Enanthate Manufacturer Copay Program: How to Cut Your Cost in 2026

Why There Is No Single Manufacturer Copay Card for Testosterone Enanthate

Testosterone enanthate lost patent protection decades ago. The original branded product, Delatestryl, was marketed by Endo Pharmaceuticals, but Endo filed for bankruptcy in 2022 and has not maintained an active copay assistance program for this formulation. Because the drug is now produced by at least four generic manufacturers (Perrigo, Hikma, Sun Pharma, and Padagis), there is no single "manufacturer coupon" the way you would find for a branded GLP-1 or a patented biologic.

This is a common point of confusion. Patients searching for a "manufacturer copay program" often expect the kind of savings card that Novo Nordisk or Lilly offers for on-patent drugs. Generic testosterone enanthate does not work this way. The savings pathways are different, and in many cases better, because generic pricing already starts low.

According to a 2020 analysis in the Journal of the Endocrine Society, testosterone replacement therapy costs in the U.S. vary widely depending on formulation, with injectable testosterone enanthate and cypionate remaining the least expensive options compared to gels, patches, and pellets. The average cash price for a 5 mL vial of 200 mg/mL testosterone enanthate sits near $70 at most retail pharmacies as of early 2026. Compounded versions average roughly $80 but can sometimes be lower depending on the compounding pharmacy's base pricing.

How to Get Testosterone Enanthate at the Lowest Price

Start with a GoodRx, RxSaver, or SingleCare coupon at your retail pharmacy. These free discount tools can drop the price of a generic testosterone enanthate vial to between $30 and $55 at major chains like Costco, Walmart, and CVS. Prices fluctuate weekly, so compare across platforms before filling.

Mark Cuban's Cost Plus Drugs (costplusdrugs.com) sells testosterone enanthate at a transparent markup of 15% over acquisition cost plus a flat pharmacist fee. For patients paying cash, this model consistently undercuts traditional retail pricing.

Compounding pharmacies offer another route. A compounding pharmacy can prepare testosterone enanthate in custom concentrations or volumes, which is particularly useful for patients on micro-dosing protocols or those who need a different carrier oil due to allergy (such as sesame oil sensitivity). The Endocrine Society's 2018 clinical practice guideline for testosterone therapy in men with hypogonadism does not specify a preferred commercial versus compounded source, giving clinicians flexibility. Average compounded cost is around $80 per vial, though some telehealth-affiliated compounding pharmacies price as low as $50 for a 10 mL vial.

A third option is 90-day supply mail-order pharmacies. Express Scripts, OptumRx, and Amazon Pharmacy frequently offer lower per-unit pricing on Schedule III injectables when dispensed in 90-day quantities. If your prescriber writes for a 90-day supply and you use a discount card, the per-injection cost can fall below $5.

Insurance Coverage for Testosterone Enanthate

Most commercial insurance plans cover generic testosterone enanthate on Tier 1 or Tier 2 of their formulary, making the typical copay $0 to $25. The drug's low acquisition cost means insurers rarely restrict it with prior authorization for patients who have a documented diagnosis of hypogonadism.

Medicare Part D also covers injectable testosterone enanthate. According to the Centers for Medicare & Medicaid Services, testosterone enanthate is classified as a self-administered injectable, placing it under Part D rather than Part B. Patients in the Part D coverage gap ("donut hole") may face higher out-of-pocket costs, but the Inflation Reduction Act's $2,000 annual out-of-pocket cap (fully effective as of 2025) limits total exposure. For a drug this inexpensive, most Medicare beneficiaries will not reach that threshold on testosterone enanthate alone.

The American Urological Association's 2018 guideline on evaluation and management of testosterone deficiency recommends confirming a diagnosis with two morning total testosterone levels below 300 ng/dL before initiating therapy. Insurers often require documentation of these two separate lab draws before approving coverage. If your claim is denied, the most common reason is insufficient lab documentation, not drug exclusion.

Tricare covers testosterone enanthate with no prior authorization for active-duty service members and retirees when prescribed for diagnosed hypogonadism. The copay is $0 at military treatment facility pharmacies and $14 at retail network pharmacies for a 90-day supply.

What to Do If Your Insurance Denies Coverage

A denial does not mean the drug is excluded from your plan. It usually means the insurer needs more clinical documentation. Here is a step-by-step approach.

First, ask your prescriber's office to submit the prior authorization with both lab values (two morning total testosterone draws below 300 ng/dL), the ICD-10 code for male hypogonadism (E29.1), and a brief clinical note explaining symptoms. The Endocrine Society's 2018 guideline provides the diagnostic criteria that most insurers reference.

Second, if the PA is denied, file a formal appeal. Include a letter of medical necessity from your physician citing the guideline recommendation that injectable testosterone is first-line therapy for symptomatic hypogonadism. Reference the 2018 Endocrine Society guideline specifically: "We recommend testosterone therapy for men with symptomatic testosterone deficiency to induce and maintain secondary sex characteristics and to improve sexual function, sense of well-being, and bone mineral density" [2].

Third, if the appeal fails, request an external review through your state's insurance department. External reviews are decided by independent physicians and overturn insurer denials in roughly 40 to 60% of cases according to data from the Kaiser Family Foundation.

While working through the appeals process, fill the prescription using a discount coupon so you do not miss doses. A gap in testosterone therapy can cause symptom recurrence within 2 to 4 weeks.

Patient Assistance Programs That Apply to Testosterone Enanthate

Although no manufacturer-specific PAP exists for generic testosterone enanthate, several broader programs can help uninsured or underinsured patients access the drug at reduced cost or free.

NeedyMeds (needymeds.org) maintains a database of generic drug assistance programs organized by state. Some states, including New York, California, and Illinois, operate pharmaceutical assistance programs that cover generic injectables for residents below 200% of the federal poverty level.

RxAssist (rxassist.org) is a similar database funded by the Robert Wood Johnson Foundation. It aggregates eligibility criteria for state, federal, and nonprofit drug assistance programs in one search interface.

340B Drug Pricing Program. Patients who receive care at federally qualified health centers (FQHCs), Ryan White HIV/AIDS Program clinics, or other 340B-covered entities can access testosterone enanthate at the 340B ceiling price, which is typically 25 to 50% below wholesale acquisition cost. The Health Resources and Services Administration (HRSA) oversees the 340B program. Ask your provider if they are a 340B-covered entity.

Veterans Affairs. VA formulary pricing for testosterone enanthate is negotiated under the Federal Supply Schedule and is among the lowest in the country. Eligible veterans can obtain testosterone enanthate through VA pharmacies at minimal or no copay depending on priority group.

A 2021 study published in JAMA Network Open found that out-of-pocket costs for testosterone replacement therapy varied as much as 10-fold depending on formulation, pharmacy, and insurance status. Injectable testosterone enanthate and cypionate were consistently the most affordable options, with median annual costs under $120 for insured patients.

Testosterone Enanthate vs. Cypionate: Does Cost Differ?

Testosterone enanthate and testosterone cypionate are pharmacologically near-identical. Both are long-acting intramuscular esters with half-lives of approximately 4.5 and 8 days, respectively. The FDA prescribing information for both products lists the same indication: replacement therapy in males for conditions associated with deficiency or absence of endogenous testosterone.

Price differences are minimal. Testosterone cypionate (the more commonly prescribed ester in the U.S.) averages $40 to $80 per vial at retail, while enanthate averages $50 to $90. The Endocrine Society's guideline does not recommend one ester over the other, and most insurance formularies cover both at the same tier.

If your pharmacy quotes a high price for enanthate, ask your prescriber about switching to cypionate or vice versa. The substitution requires only a new prescription, not a new diagnosis or prior authorization in most cases. A 2019 pharmacokinetic comparison in the Journal of Clinical Endocrinology & Metabolism confirmed that steady-state testosterone levels are comparable between the two esters when dosed at equivalent milligram amounts on the same schedule.

How Telehealth TRT Clinics Price Testosterone Enanthate

Telehealth testosterone clinics (including HealthRX) bundle the cost of testosterone enanthate with physician consultations, lab monitoring, and supplies. Monthly pricing at telehealth TRT providers typically ranges from $99 to $199 per month, which includes the medication, syringes, alcohol swabs, and quarterly or semiannual lab panels.

This bundled model can be more economical than paying separately for a primary care visit ($150 to $300 without insurance), lab work ($100 to $400 for a comprehensive hormone panel), and the medication itself. For uninsured patients, telehealth TRT programs often represent the lowest total cost of care.

When comparing telehealth providers, verify three things. The provider should use a licensed U.S. pharmacy (not an overseas source). The protocol should include baseline and follow-up labs, including hematocrit monitoring, because the FDA requires a boxed warning about polycythemia risk with all testosterone products. The prescriber should be a licensed physician or advanced practice provider, not an unlicensed "hormone coach."

The Endocrine Society recommends monitoring hematocrit at baseline, 3 to 6 months after starting therapy, and annually thereafter [2]. A hematocrit above 54% is the threshold for dose reduction or temporary discontinuation per the 2018 guideline.

Tips for Keeping Long-Term TRT Costs Low

Use a 10 mL vial instead of a 1 mL vial when possible. The per-milligram cost of the larger vial is substantially lower. A 10 mL vial of 200 mg/mL testosterone enanthate contains 2,000 mg total. At a dose of 100 mg per week, one vial lasts 20 weeks (nearly 5 months).

Store vials properly. Testosterone enanthate is stable at controlled room temperature (68 to 77°F) and does not require refrigeration. Multi-dose vials contain a preservative (chlorobutanol or benzyl alcohol) that allows use for up to 28 days after first puncture per CDC multi-dose vial guidelines, though many clinicians permit longer use for testosterone due to its antimicrobial carrier oil.

Learn to self-inject. Office-administered intramuscular injections add a $20 to $50 nursing visit charge each time. Self-injection at home, using the dorsogluteal or ventrogluteal site, eliminates this recurring cost entirely. Your prescriber or clinic nurse can teach proper technique in a single training session. Subcutaneous injection of testosterone enanthate (into abdominal fat) is also used off-label and may be more comfortable for some patients. A 2017 study in Translational Andrology and Urology found that subcutaneous testosterone injections produced comparable serum levels to intramuscular administration.

Request 90-day prescriptions filled through mail-order. Most pharmacy benefit managers offer lower copays for 90-day fills versus three separate 30-day fills.